把三张表、经营指标、SEC / 巨潮 / 港交所原始财报、业绩材料和电话会放到同一条可核验时间线上。 披露事实、结构化补位值与派生指标分开标注，缺失逐字稿不会用摘要或模型生成内容补齐。
单季、累计、年度和资产负债表时点分开保存；每个数值都保留单位、申报日、表单、XBRL 概念或原始中文字段。
美股链接 SEC 法定申报和发行人 IR，A 股链接巨潮原始 PDF，港股链接港交所披露易原始年报与中报。分部、订单、产能和客户集中度只在有可核验披露时展示。
官方电话会入口与已授权逐字稿分开。没有合法取得的全文时只显示材料可用性，不生成或拼接虚假的逐字稿。
三张表会执行资产负债、毛利润、税前利润等勾稽检查；超出容差的记录保留原值并标记警告， 不会为了让公式“对上”而修改公司披露。
| 2026-06-30 |
| 3/3 |
| $103.55M |
| -$2.06M |
| -$28.03M |
| 77.1% |
| -3.0% |
| 85 |
| 尚无授权文本 |
| TCBIO TEXAS CAPITAL BANCSHARES INC/TX | 2026-06-30 | 3/3 | — | $84.95M | $179.67M | — | — | 77 | 尚无授权文本 |
| LEXX Lexaria Bioscience Corp. | 2026-05-31 | 3/3 | $0 | -$1.99M | -$4.82M | 100.0% | -25096.7% | 103 | 尚无授权文本 |
| ANIX Anixa Biosciences Inc | 2026-04-30 | 3/3 | — | -$2.52M | — | — | — | 50 | 尚无授权文本 |
| PMCB PharmaCyte Biotech, Inc. | 2026-04-30 | 3/3 | $0 | -$19.42M | — | — | — | 70 | 尚无授权文本 |
| ABCL AbCellera Biologics Inc. | 2026-03-31 | 3/3 | $8.32M | -$43.17M | -$37.35M | — | -691.7% | 80 | 尚无授权文本 |
| ABUS Arbutus Biopharma Corp | 2026-03-31 | 3/3 | $179.13M | $169.7M | — | — | 94.3% | 139 | 尚无授权文本 |
| ABVC ABVC BIOPHARMA, INC. | 2026-03-31 | 3/3 | — | -$1.56M | — | — | — | 99 | 尚无授权文本 |
| ACET Adicet Bio, Inc. | 2026-03-31 | 3/3 | — | -$20.24M | -$21.53M | — | — | 125 | 尚无授权文本 |
| ADMA ADMA BIOLOGICS, INC. | 2026-03-31 | 3/3 | $114.49M | $45.33M | $55.71M | 70.5% | 50.9% | 127 | 尚无授权文本 |
| ADPT Adaptive Biotechnologies Corp | 2026-03-31 | 3/3 | $70.87M | -$20.03M | -$10.33M | 73.6% | -27.1% | 78 | 尚无授权文本 |
| ADVB Advanced Biomed Inc. | 2026-03-31 | 3/3 | — | -$488,942 | -$1.38M | — | — | 24 | 尚无授权文本 |
| AEON AEON Biopharma, Inc. | 2026-03-31 | 3/3 | — | -$11.79M | — | — | — | 104 | 尚无授权文本 |
| AIDX 20/20 Biolabs, Inc. | 2026-03-31 | 3/3 | $353,375 | -$2.17M | — | 17.8% | -408.4% | 8 | 尚无授权文本 |
| ALMR Alamar Biosciences, Inc. | 2026-03-31 | 3/3 | $26.04M | -$21.33M | -$20.95M | 55.5% | -47.4% | 4 | 尚无授权文本 |
| ANAB ANAPTYSBIO, INC | 2026-03-31 | 3/3 | $25.56M | -$52.88M | -$25.94M | — | -135.5% | 104 | 尚无授权文本 |
| ANVS Annovis Bio, Inc. | 2026-03-31 | 3/3 | $0 | -$17.61M | — | — | — | 99 | 尚无授权文本 |
| ARQT Arcutis Biotherapeutics, Inc. | 2026-03-31 | 3/3 | $105.4M | -$11.3M | $2.24M | 90.7% | -8.6% | 91 | 尚无授权文本 |
| ARTL ARTELO BIOSCIENCES, INC. | 2026-03-31 | 3/3 | — | -$2.96M | — | — | — | 84 | 尚无授权文本 |
| ARTV Artiva Biotherapeutics, Inc. | 2026-03-31 | 3/3 | — | -$23.52M | -$21.19M | — | — | 27 | 尚无授权文本 |
| ASBP Aspire Biopharma Holdings, Inc. | 2026-03-31 | 3/3 | $28,353 | -$3.22M | — | 20.3% | -5806.0% | 71 | 尚无授权文本 |
| ASMB ASSEMBLY BIOSCIENCES, INC. | 2026-03-31 | 3/3 | — | -$9.08M | -$22.12M | — | — | 97 | 尚无授权文本 |
| ATRA Atara Biotherapeutics, Inc. | 2026-03-31 | 3/3 | $516,000 | -$4.15M | — | — | -652.9% | 109 | 尚无授权文本 |
| AURA Aura Biosciences, Inc. | 2026-03-31 | 3/3 | — | -$33.69M | -$30M | — | — | 69 | 尚无授权文本 |
| AVBP ArriVent BioPharma, Inc. | 2026-03-31 | 3/3 | — | -$43.32M | — | — | — | 36 | 尚无授权文本 |
| AYTU AYTU BIOPHARMA, INC | 2026-03-31 | 3/3 | $12.41M | -$5.62M | -$1.14M | 61.2% | -32.7% | 132 | 尚无授权文本 |
| BBIO BridgeBio Pharma, Inc. | 2026-03-31 | 3/3 | $194.52M | -$166.56M | -$197.35M | 94.9% | -54.5% | 109 | 尚无授权文本 |
| BBLG Bone Biologics Corp | 2026-03-31 | 3/3 | — | -$765,988 | — | — | — | 74 | 尚无授权文本 |
| BBOT BridgeBio Oncology Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$42.11M | -$35.94M | — | — | 26 | 尚无授权文本 |
| BCAB BioAtla, Inc. | 2026-03-31 | 3/3 | — | -$6.34M | — | — | — | 85 | 尚无授权文本 |
| BCDA BioCardia, Inc. | 2026-03-31 | 3/3 | — | -$2.26M | -$1.66M | — | — | 190 | 尚无授权文本 |
| BCRX BIOCRYST PHARMACEUTICALS INC | 2026-03-31 | 3/3 | — | -$721.81M | — | — | — | 132 | 尚无授权文本 |
| BDSX BIODESIX INC | 2026-03-31 | 3/3 | $25.56M | -$7.79M | -$10.25M | — | -24.3% | 76 | 尚无授权文本 |
| BFRI Biofrontera Inc. | 2026-03-31 | 3/3 | $10.08M | -$4.75M | -$75,000 | — | -42.8% | 116 | 尚无授权文本 |
| BGLC BioNexus Gene Lab Corp | 2026-03-31 | 3/3 | $22,842 | -$543,575 | -$147,996 | -3.5% | -2366.2% | 70 | 尚无授权文本 |
| BGMS Bio Green Med Solution, Inc. | 2026-03-31 | 3/3 | $743,000 | -$197,000 | -$279,000 | — | -33.1% | 136 | 尚无授权文本 |
| BHVN Biohaven Ltd. | 2026-03-31 | 3/3 | — | -$130.53M | -$149.92M | — | — | 64 | 尚无授权文本 |
| BIAF bioAffinity Technologies, Inc. | 2026-03-31 | 3/3 | $1.35M | -$3.63M | -$3.23M | — | -267.6% | 123 | 尚无授权文本 |
| BIIB BIOGEN INC. | 2026-03-31 | 3/3 | $2.48B | $319.5M | $594.3M | 73.3% | — | 85 | 尚无授权文本 |
| BIO BIO-RAD LABORATORIES, INC. | 2026-03-31 | 3/3 | $592.1M | -$527.1M | $78.1M | 52.3% | 5.8% | 81 | 尚无授权文本 |
| BIOA BioAge Labs, Inc. | 2026-03-31 | 3/3 | $2.77M | -$22.25M | -$24.07M | — | -915.4% | 22 | 尚无授权文本 |
| BIVI BIOVIE INC. | 2026-03-31 | 3/3 | — | -$5.27M | — | — | — | 79 | 尚无授权文本 |
| BKYI BIO KEY INTERNATIONAL INC | 2026-03-31 | 3/3 | — | -$205,037 | -$358,001 | — | — | 99 | 尚无授权文本 |
| BLFS BIOLIFE SOLUTIONS INC | 2026-03-31 | 3/3 | — | $1.19M | -$658,000 | — | — | 96 | 尚无授权文本 |
| BMEA Biomea Fusion, Inc. | 2026-03-31 | 3/3 | — | -$12.42M | — | — | — | 91 | 尚无授权文本 |
| BMRN BIOMARIN PHARMACEUTICAL INC | 2026-03-31 | 3/3 | $766.21M | $105.53M | $199.73M | 74.6% | 16.9% | 91 | 尚无授权文本 |
| BNGO Bionano Genomics, Inc. | 2026-03-31 | 3/3 | $6.69M | -$8.3M | — | 48.6% | -118.1% | 112 | 尚无授权文本 |
| BNTC Benitec Biopharma Inc. | 2026-03-31 | 3/3 | $0 | -$11.94M | -$11.61M | — | — | 97 | 尚无授权文本 |
| BOLD Boundless Bio, Inc. | 2026-03-31 | 3/3 | — | -$13.56M | -$14.98M | — | — | 28 | 尚无授权文本 |
| BOLT Bolt Biotherapeutics, Inc. | 2026-03-31 | 3/3 | $26,000 | -$7.24M | — | — | -29234.6% | 65 | 尚无授权文本 |
| BRNS Barinthus Biotherapeutics plc. | 2026-03-31 | 3/3 | — | -$5.53M | -$3.37M | — | — | 74 | 尚无授权文本 |
| BRTX BioRestorative Therapies, Inc. | 2026-03-31 | 3/3 | $23,170 | -$2.15M | — | 68.1% | -14612.6% | 74 | 尚无授权文本 |
| BTAI BioXcel Therapeutics, Inc. | 2026-03-31 | 3/3 | $206,000 | -$12.69M | -$11.81M | -37.4% | -4962.6% | 142 | 尚无授权文本 |
| BTMD biote Corp. | 2026-03-31 | 3/3 | $44.94M | $2.28M | $3.54M | — | 7.0% | 83 | 尚无授权文本 |
| CABA Cabaletta Bio, Inc. | 2026-03-31 | 3/3 | — | -$43.52M | -$42.56M | — | — | 105 | 尚无授权文本 |
| CLDI Calidi Biotherapeutics, Inc. | 2026-03-31 | 3/3 | — | -$4.11M | — | — | — | 119 | 尚无授权文本 |
| CLRB Cellectar Biosciences, Inc. | 2026-03-31 | 3/3 | — | -$5.65M | -$4.85M | — | — | 126 | 尚无授权文本 |
| CLYM Climb Bio, Inc. | 2026-03-31 | 3/3 | — | -$13.72M | — | — | — | 79 | 尚无授权文本 |
| CNTB Connect Biopharma Holdings Ltd | 2026-03-31 | 3/3 | $169,000 | -$19.4M | -$16.01M | — | -11601.8% | 75 | 尚无授权文本 |
| COGT Cogent Biosciences, Inc. | 2026-03-31 | 3/3 | — | -$97.35M | -$87.33M | — | — | 83 | 尚无授权文本 |
| CRBU Caribou Biosciences, Inc. | 2026-03-31 | 3/3 | $2.4M | -$25.09M | -$27.06M | — | -1096.4% | 89 | 尚无授权文本 |
| CTKB Cytek Biosciences, Inc. | 2026-03-31 | 3/3 | $44.14M | -$18.87M | -$4.9M | 48.2% | -41.8% | 63 | 尚无授权文本 |
| CUE Cue Biopharma, Inc. | 2026-03-31 | 3/3 | $5.69M | -$5.18M | -$11.06M | — | -94.1% | 76 | 尚无授权文本 |
| DARE Dare Bioscience, Inc. | 2026-03-31 | 3/3 | $152,455 | -$3M | -$5.52M | -58.9% | -1967.1% | 139 | 尚无授权文本 |
| DNA Ginkgo Bioworks Holdings, Inc. | 2026-03-31 | 3/3 | $19.47M | -$82.59M | -$48.62M | 84.1% | -366.5% | 44 | 尚无授权文本 |
| DTIL PRECISION BIOSCIENCES INC | 2026-03-31 | 3/3 | $10.84M | -$18.44M | — | — | -83.7% | 126 | 尚无授权文本 |
| EBS Emergent BioSolutions Inc. | 2026-03-31 | 3/3 | $156.1M | $6.8M | -$36.2M | 53.9% | 6.7% | 137 | 尚无授权文本 |
| EDSA Edesa Biotech, Inc. | 2026-03-31 | 3/3 | — | -$4.22M | — | — | — | 87 | 尚无授权文本 |
| ENSC Ensysce Biosciences, Inc. | 2026-03-31 | 3/3 | $960,999 | -$3.56M | — | — | -370.7% | 122 | 尚无授权文本 |
| ENTX Entera Bio Ltd. | 2026-03-31 | 3/3 | $0 | -$3.51M | -$3.09M | — | — | 102 | 尚无授权文本 |
| ENVB Enveric Biosciences, Inc. | 2026-03-31 | 3/3 | — | -$1.63M | — | — | — | 172 | 尚无授权文本 |
| FBIO Fortress Biotech, Inc. | 2026-03-31 | 3/3 | $16.04M | $110.37M | — | 61.2% | -48.3% | 104 | 尚无授权文本 |
| FBIOP Fortress Biotech, Inc. | 2026-03-31 | 3/3 | $16.04M | $110.37M | — | 61.2% | -48.3% | 104 | 尚无授权文本 |
| FBLG FibroBiologics, Inc. | 2026-03-31 | 3/3 | — | -$5M | -$4.36M | — | — | 52 | 尚无授权文本 |
| FBRX Forte Biosciences, Inc. | 2026-03-31 | 3/3 | — | -$22.14M | -$18.81M | — | — | 78 | 尚无授权文本 |
| GENB Generate Biomedicines, Inc. | 2026-03-31 | 3/3 | $7.22M | -$61.45M | -$84.17M | — | -887.5% | 3 | 尚无授权文本 |
| GOSS Gossamer Bio, Inc. | 2026-03-31 | 3/3 | $16.96M | -$46.66M | -$38.72M | — | -264.6% | 86 | 尚无授权文本 |
| GRI GRI Bio, Inc. | 2026-03-31 | 3/3 | — | -$2M | — | — | — | 120 | 尚无授权文本 |
| GTBP GT Biopharma, Inc. | 2026-03-31 | 3/3 | — | -$2.83M | — | — | — | 90 | 尚无授权文本 |
| HBIO HARVARD BIOSCIENCE INC | 2026-03-31 | 3/3 | $20.76M | -$3.42M | -$1.09M | 59.0% | -5.7% | 89 | 尚无授权文本 |
| HCWB HCW Biologics Inc. | 2026-03-31 | 3/3 | $6.5M | $3.47M | — | 100.5% | 49.8% | 111 | 尚无授权文本 |
| HRMY Harmony Biosciences Holdings, Inc. | 2026-03-31 | 3/3 | $215.39M | $32.49M | — | 79.3% | 17.3% | 94 | 尚无授权文本 |
| HURA TuHURA Biosciences, Inc./NV | 2026-03-31 | 3/3 | $0 | -$7.54M | -$4.46M | — | — | 142 | 尚无授权文本 |
| IBIO iBio, Inc. | 2026-03-31 | 3/3 | $100,000 | -$7.73M | -$17.55M | — | -23761.0% | 146 | 尚无授权文本 |
| IBO IMPACT BIOMEDICAL INC. | 2026-03-31 | 3/3 | $7,000 | -$2.29M | — | — | -32700.0% | 27 | 尚无授权文本 |
| IBRX ImmunityBio, Inc. | 2026-03-31 | 3/3 | $44.21M | -$632.78M | -$77.14M | 99.5% | -157.9% | 101 | 尚无授权文本 |
| IDYA IDEAYA Biosciences, Inc. | 2026-03-31 | 3/3 | $6.56M | -$98.54M | -$76.14M | — | -1654.6% | 111 | 尚无授权文本 |
| IMA ImageneBio, Inc. | 2026-03-31 | 3/3 | — | -$10.62M | — | — | — | 73 | 尚无授权文本 |
| IMMX Immix Biopharma, Inc. | 2026-03-31 | 3/3 | — | -$10.09M | -$9.86M | — | — | 49 | 尚无授权文本 |
| INAB IN8BIO, INC. | 2026-03-31 | 3/3 | — | -$5.09M | — | — | — | 94 | 尚无授权文本 |
| INBS INTELLIGENT BIO SOLUTIONS INC. | 2026-03-31 | 3/3 | $1.06M | -$2.86M | -$8.87M | 50.5% | -277.8% | 178 | 尚无授权文本 |
| INBX Inhibrx Biosciences, Inc. | 2026-03-31 | 3/3 | — | -$33.44M | -$38.03M | — | — | 32 | 尚无授权文本 |
| INMB Inmune Bio, Inc. | 2026-03-31 | 3/3 | — | -$5.41M | — | — | — | 231 | 尚无授权文本 |
| IOVA IOVANCE BIOTHERAPEUTICS, INC. | 2026-03-31 | 3/3 | $71.43M | -$79.05M | -$78.68M | 40.5% | -113.5% | 119 | 尚无授权文本 |
| JBIO Jade Biosciences, Inc. | 2026-03-31 | 3/3 | — | -$40.37M | — | — | — | 77 | 尚无授权文本 |
| KALA KALA BIO, Inc. | 2026-03-31 | 3/3 | — | -$1.62M | — | — | — | 103 | 尚无授权文本 |
| KRRO Korro Bio, Inc. | 2026-03-31 | 3/3 | $0 | -$19.63M | -$16.1M | — | — | 104 | 尚无授权文本 |
| KRYS Krystal Biotech, Inc. | 2026-03-31 | 3/3 | $116.36M | $55.93M | $73.23M | — | 46.1% | 103 | 尚无授权文本 |
| KYNB KYNTRA BIO, INC. | 2026-03-31 | 3/3 | $3.74M | -$15.2M | -$13.89M | -9.8% | -369.7% | 105 | 尚无授权文本 |
| LAB STANDARD BIOTOOLS INC. | 2026-03-31 | 3/3 | $21.15M | $127.07M | -$47.17M | 53.5% | -59.1% | 108 | 尚无授权文本 |
| LABT Lakewood-Amedex Biotherapeutics Inc. | 2026-03-31 | 3/3 | — | -$923,291 | — | — | — | 4 | 尚无授权文本 |
| LFCR LIFECORE BIOMEDICAL, INC. \DE\ | 2026-03-31 | 3/3 | — | -$14.98M | $3.58M | — | — | 120 | 尚无授权文本 |
| LNAI Lunai Bioworks Inc. | 2026-03-31 | 3/3 | $20,942 | -$2.57M | -$3.45M | 100.0% | -7054.1% | 134 | 尚无授权文本 |
| LONA LeonaBio, Inc. | 2026-03-31 | 3/3 | — | -$32.95M | — | — | — | 76 | 尚无授权文本 |
| MAIA MAIA Biotechnology, Inc. | 2026-03-31 | 3/3 | — | -$6.37M | — | — | — | 124 | 尚无授权文本 |
| MBIO MUSTANG BIO, INC. | 2026-03-31 | 3/3 | — | -$955,000 | — | — | — | 97 | 尚无授权文本 |
| MBRX Moleculin Biotech, Inc. | 2026-03-31 | 3/3 | $0 | -$12.85M | — | — | — | 287 | 尚无授权文本 |
| MBX MBX Biosciences, Inc. | 2026-03-31 | 3/3 | — | -$23.52M | -$20.65M | — | — | 32 | 尚无授权文本 |
| MREO Mereo BioPharma Group plc | 2026-03-31 | 3/3 | — | -$6.72M | -$4.31M | — | — | 114 | 尚无授权文本 |
| MTNB Matinas BioPharma Holdings, Inc. | 2026-03-31 | 3/3 | — | -$1.92M | — | — | — | 107 | 尚无授权文本 |
| NAGE Niagen Bioscience, Inc. | 2026-03-31 | 3/3 | $31.47M | $6.32M | — | 63.5% | 5.0% | 91 | 尚无授权文本 |
| NAUT Nautilus Biotechnology, Inc. | 2026-03-31 | 3/3 | — | -$14.7M | -$13.61M | — | — | 65 | 尚无授权文本 |
| NBIX NEUROCRINE BIOSCIENCES INC | 2026-03-31 | 3/3 | $814.5M | $197.9M | $136.7M | 98.3% | 23.7% | 90 | 尚无授权文本 |
| NUVB Nuvation Bio Inc. | 2026-03-31 | 3/3 | $83.23M | $5.4M | — | — | 4.7% | 80 | 尚无授权文本 |
| OBIO Orchestra BioMed Holdings, Inc. | 2026-03-31 | 3/3 | $110,000 | -$20.69M | -$22.35M | 70.9% | -20069.1% | 64 | 尚无授权文本 |
| ONCY ONCOLYTICS BIOTECH INC | 2026-03-31 | 3/3 | — | -$9.24M | -$7.3M | — | — | 229 | 尚无授权文本 |
| PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 2026-03-31 | 3/3 | $37.18M | -$8.28M | -$47.73M | 34.5% | -22.5% | 105 | 尚无授权文本 |
| PALI PALISADE BIO, INC. | 2026-03-31 | 3/3 | — | -$9.6M | — | — | — | 103 | 尚无授权文本 |
| PASG Passage BIO, Inc. | 2026-03-31 | 3/3 | — | -$7.56M | — | — | — | 106 | 尚无授权文本 |
| PBYI PUMA BIOTECHNOLOGY, INC. | 2026-03-31 | 3/3 | $44.81M | -$3.75M | $15.42M | 76.7% | -8.5% | 83 | 尚无授权文本 |
| PCRX Pacira BioSciences, Inc. | 2026-03-31 | 3/3 | $177.38M | $2.92M | $22.96M | 79.5% | 3.9% | 112 | 尚无授权文本 |
| PDSB PDS Biotechnology Corp | 2026-03-31 | 3/3 | — | -$7.35M | — | — | — | 204 | 尚无授权文本 |
| PHGE BiomX Inc. | 2026-03-31 | 3/3 | — | -$19.14M | — | — | — | 121 | 尚无授权文本 |
| PLSE PULSE BIOSCIENCES, INC. | 2026-03-31 | 3/3 | $401,000 | -$18.58M | -$14.63M | 7.7% | -4775.6% | 140 | 尚无授权文本 |
| PLX Protalix BioTherapeutics, Inc. | 2026-03-31 | 3/3 | $33.75M | $18.32M | $21.26M | 87.8% | 62.7% | 101 | 尚无授权文本 |
| PPCB Propanc Biopharma, Inc. | 2026-03-31 | 3/3 | — | -$6.36M | -$4.09M | — | — | 93 | 尚无授权文本 |
| PRCT PROCEPT BioRobotics Corp | 2026-03-31 | 3/3 | $83.13M | -$31.64M | -$41.04M | 64.9% | -39.2% | 64 | 尚无授权文本 |
| QTTB Q32 Bio Inc. | 2026-03-31 | 3/3 | — | -$7.61M | — | — | — | 80 | 尚无授权文本 |
| RCUS Arcus Biosciences, Inc. | 2026-03-31 | 3/3 | $7M | -$128M | -$138M | — | -1914.3% | 89 | 尚无授权文本 |
| REVB REVELATION BIOSCIENCES, INC. | 2026-03-31 | 3/3 | — | -$3.01M | -$3.29M | — | — | 117 | 尚无授权文本 |
| RGNX REGENXBIO Inc. | 2026-03-31 | 3/3 | $6.39M | -$90.05M | -$77.42M | — | -1304.0% | 86 | 尚无授权文本 |
| RKDA Arcadia Biosciences, Inc. | 2026-03-31 | 3/3 | $1.1M | -$4.39M | — | 36.4% | -70.8% | 91 | 尚无授权文本 |
| RLYB Rallybio Corp | 2026-03-31 | 3/3 | $212,000 | -$8.28M | — | — | -4119.3% | 68 | 尚无授权文本 |
| RPID RAPID MICRO BIOSYSTEMS, INC. | 2026-03-31 | 3/3 | $8M | -$14.28M | -$15.45M | 4.6% | -173.1% | 66 | 尚无授权文本 |
| SABS SAB Biotherapeutics, Inc. | 2026-03-31 | 3/3 | — | -$18.87M | -$15.25M | — | — | 101 | 尚无授权文本 |
| SANA Sana Biotechnology, Inc. | 2026-03-31 | 3/3 | — | -$47.21M | -$37.67M | — | — | 87 | 尚无授权文本 |
| SBFM Sunshine Biopharma Inc. | 2026-03-31 | 3/3 | $8.09M | -$1.24M | -$2.08M | 27.0% | -17.3% | 87 | 尚无授权文本 |
| SGMT Sagimet Biosciences Inc. | 2026-03-31 | 3/3 | — | -$10.65M | — | — | — | 60 | 尚无授权文本 |
| SKYE Skye Bioscience, Inc. | 2026-03-31 | 3/3 | — | -$12.51M | -$8.56M | — | — | 82 | 尚无授权文本 |
| SLDB Solid Biosciences Inc. | 2026-03-31 | 3/3 | — | -$56.74M | -$47.4M | — | — | 69 | 尚无授权文本 |
| SNTI Senti Biosciences Holdings, Inc. | 2026-03-31 | 3/3 | $16,000 | -$4.22M | — | — | -28850.0% | 91 | 尚无授权文本 |
| SPRB SPRUCE BIOSCIENCES, INC. | 2026-03-31 | 3/3 | — | -$12.27M | -$8.74M | — | — | 85 | 尚无授权文本 |
| STRO SUTRO BIOPHARMA, INC. | 2026-03-31 | 3/3 | $14.52M | -$38.48M | — | — | -204.2% | 96 | 尚无授权文本 |
| TBPH Theravance Biopharma, Inc. | 2026-03-31 | 3/3 | $17.7M | -$4.93M | — | — | -53.6% | 102 | 尚无授权文本 |
| TECH BIO-TECHNE Corp | 2026-03-31 | 3/3 | $311.42M | $51.05M | $176.29M | 66.9% | 24.2% | 66 | 尚无授权文本 |
| TELA TELA Bio, Inc. | 2026-03-31 | 3/3 | $19.06M | -$12.27M | -$11.29M | 65.7% | -55.2% | 93 | 尚无授权文本 |
| TIL Instil Bio, Inc. | 2026-03-31 | 3/3 | — | -$4.2M | — | — | — | 87 | 尚无授权文本 |
| TOVX Theriva Biologics, Inc. | 2026-03-31 | 3/3 | $300,000 | -$2.04M | — | — | -709.0% | 150 | 尚无授权文本 |
| TRAX First Tracks Biotherapeutics, Inc. | 2026-03-31 | 3/3 | — | -$50.48M | -$32.58M | — | — | 5 | 尚无授权文本 |
| TVGN Tevogen Bio Holdings Inc. | 2026-03-31 | 3/3 | — | -$5.45M | — | — | — | 63 | 尚无授权文本 |
| TWST Twist Bioscience Corp | 2026-03-31 | 3/3 | — | -$44.02M | -$60.23M | — | — | 54 | 尚无授权文本 |
| TYRA Tyra Biosciences, Inc. | 2026-03-31 | 3/3 | — | -$39.31M | -$32.66M | — | — | 62 | 尚无授权文本 |
| UPB Upstream Bio, Inc. | 2026-03-31 | 3/3 | $1.03M | -$40.59M | — | — | -4218.1% | 21 | 尚无授权文本 |
| VBIO Valion Bio, Inc. | 2026-03-31 | 3/3 | — | -$6.2M | -$5.02M | — | — | 112 | 尚无授权文本 |
| VIR Vir Biotechnology, Inc. | 2026-03-31 | 3/3 | -$29,000 | -$125.7M | -$132.78M | — | 456172.4% | 108 | 尚无授权文本 |
| VOR Vor Biopharma Inc. | 2026-03-31 | 3/3 | — | -$219.59M | -$38.29M | — | — | 70 | 尚无授权文本 |
| XBIO Xenetic Biosciences, Inc. | 2026-03-31 | 3/3 | $806,923 | -$456,382 | — | — | -62.2% | 81 | 尚无授权文本 |
| XBIT XBiotech Inc. | 2026-03-31 | 3/3 | — | -$5.51M | -$8.97M | — | — | 39 | 尚无授权文本 |
| XERS Xeris Biopharma Holdings, Inc. | 2026-03-31 | 3/3 | $83.13M | $2.23M | — | — | 9.5% | 72 | 尚无授权文本 |
| ZBH ZIMMER BIOMET HOLDINGS, INC. | 2026-03-31 | 3/3 | $2.09B | $238.1M | $323.1M | 72.4% | 17.9% | 99 | 尚无授权文本 |
| ZBIO Zenas BioPharma, Inc. | 2026-03-31 | 3/3 | — | -$80.99M | -$75.2M | — | — | 25 | 尚无授权文本 |
| ZURA Zura Bio Ltd | 2026-03-31 | 3/3 | — | -$24.22M | -$18.94M | — | — | 119 | 尚无授权文本 |
| BVS Bioventus Inc. | 2026-03-28 | 3/3 | $132.09M | $3.11M | $8.36M | 68.7% | 6.4% | 91 | 尚无授权文本 |
| BMRA BIOMERICA INC | 2026-02-28 | 3/3 | $987,000 | -$1.31M | — | -4.5% | -131.5% | 59 | 尚无授权文本 |
| BDRX Biodexa Pharmaceuticals Plc | 2025-12-31 | 2/3 | — | -$6.38M | — | — | — | 141 | 尚无授权文本 |
| BHST BIOHARVEST SCIENCES INC. | 2025-12-31 | 3/3 | $34.51M | -$11.14M | -$9.58M | 59.3% | -16.2% | 85 | 尚无授权文本 |
| BIOX Bioceres Crop Solutions Corp. | 2025-12-31 | 2/3 | — | -$182.47M | — | — | — | 103 | 尚无授权文本 |
| BLRX BioLineRx Ltd. | 2025-12-31 | 2/3 | — | -$2.03M | — | — | — | 113 | 尚无授权文本 |
| BLTE BELITE BIO, INC | 2025-12-31 | 3/3 | — | -$77.61M | -$37.06M | — | — | 56 | 尚无授权文本 |
| BNR Burning Rock Biotech Ltd | 2025-12-31 | 3/3 | $539.57M | -$55.35M | -$4.82M | 74.7% | -10.2% | 62 | 尚无授权文本 |
| BNTX BioNTech SE | 2025-12-31 | 2/3 | — | -$1.14B | — | — | — | 326 | 尚无授权文本 |
| CANF Can-Fite BioPharma Ltd. | 2025-12-31 | 3/3 | $405,000 | -$9.83M | -$8.95M | — | -2456.8% | 221 | 尚无授权文本 |
| CLGN CollPlant Biotechnologies Ltd | 2025-12-31 | 3/3 | $2.37M | -$11.49M | -$9.45M | 64.8% | -484.3% | 111 | 尚无授权文本 |
| LEGN Legend Biotech Corp | 2025-12-31 | 2/3 | — | -$296.8M | — | — | — | 190 | 尚无授权文本 |
| LKFT Lakefront Biotherapeutics NV | 2025-12-31 | 2/3 | — | $320.88M | — | — | — | 215 | 尚无授权文本 |
| MENS Jyong Biotech Ltd. | 2025-12-31 | 3/3 | — | -$4.67M | — | — | — | 4 | 尚无授权文本 |
| MSLE Satellos Bioscience Inc. | 2025-12-31 | 2/3 | — | -$24.87M | — | — | — | 20 | 尚无授权文本 |
| NBP NovaBridge Biosciences | 2025-12-31 | 3/3 | — | -$46.27M | — | — | — | 148 | 尚无授权文本 |
| NBTX Nanobiotix S.A. | 2025-12-31 | 2/3 | — | -$23.96M | — | — | — | 229 | 尚无授权文本 |
| NNNN Anbio Biotechnology | 2025-12-31 | 3/3 | $8.65M | $6.4M | — | 87.2% | 66.7% | 9 | 尚无授权文本 |
| PPBT PURPLE BIOTECH LTD. | 2025-12-31 | 3/3 | — | -$26.49M | — | — | — | 175 | 尚无授权文本 |
| QNTM Quantum Biopharma Ltd. | 2025-12-31 | 2/3 | — | — | — | — | — | 272 | 尚无授权文本 |
| RGNT REGENTIS BIOMATERIALS LTD. | 2025-12-31 | 3/3 | — | -$13.65M | — | — | — | 18 | 尚无授权文本 |
| YDES YD Bio Ltd | 2025-12-31 | 3/3 | $596,817 | -$8.31M | -$8.04M | 28.1% | -883.3% | 13 | 尚无授权文本 |
| ZYBT Zhengye Biotechnology Holding Ltd | 2025-12-31 | 3/3 | $116.36M | -$69.78M | $1.77M | 20.5% | -60.6% | 13 | 尚无授权文本 |
| BYAH Park Ha Biological Technology Co., Ltd. | 2025-10-31 | 3/3 | $2.52M | -$24.36M | — | 94.4% | -956.5% | 29 | 尚无授权文本 |
| HKPD Cellyan Biotechnology Co., Ltd | 2025-09-30 | 2/3 | — | $153,735 | — | — | — | 13 | 尚无授权文本 |
| PASW Ping An Biomedical Co., Ltd. | 2025-09-30 | 3/3 | $34.15M | -$12.83M | — | 2.8% | -43.1% | 16 | 尚无授权文本 |
| PBM PSYENCE BIOMEDICAL LTD. | 2025-09-30 | 2/3 | — | -$753,254 | — | — | — | 59 | 尚无授权文本 |
| RDHL RedHill Biopharma Ltd. | 2025-06-30 | 2/3 | — | -$4.13M | — | — | — | 306 | 尚无授权文本 |
| RGC Regencell Bioscience Holdings Ltd | 2025-06-30 | 3/3 | — | -$3.58M | -$3.27M | — | — | 39 | 尚无授权文本 |
| VRAX Virax Biolabs Group Ltd | 2025-03-31 | 2/3 | — | -$6.07M | — | — | — | 73 | 尚无授权文本 |
| TRIB TRINITY BIOTECH PLC | 2024-12-31 | 2/3 | — | -$31.22M | — | — | — | 143 | 尚无授权文本 |
| XTLB XTL BIOPHARMACEUTICALS LTD | 2024-12-31 | 2/3 | — | -$1.03M | — | — | — | 75 | 尚无授权文本 |
| BIOT INSTINCT BIO TECHNICAL CO HOLDINGS INC. | — | 0/3 | — | — | — | — | — | 3 | 尚无授权文本 |